High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B
2017 · Gut · 252 citations
https://doi.org/10.1136/gutjnl-2017-314904
J
Jonggi Choi
Ulsan College(KR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
218
Papers
3.1K
Citations
31
h-index
63
i10-index
Jonggi Choi is an academic researcher from Ulsan College. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Hepatitis B Virus Studies & Hepatocellular Carcinoma Treatment and Prognosis. The author has an h-index of 31, co-authored 186 publications.
ORCID: 0000-0002-7470-5850Papers by this author
worksAspirin use and the risk of cholangiocarcinoma‡
2016 · Hepatology · 110 citations
https://doi.org/10.1002/hep.28529
Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trial
2025 · The Lancet. Gastroenterology & hepatology · 19 citations
https://doi.org/10.1016/s2468-1253(24)00431-x
Surveillance for Hepatocellular Carcinoma Reduces Mortality: an Inverse Probability of Treatment Weighted Analysis
2017 · Annals of Hepatology · 18 citations
https://doi.org/10.5604/01.3001.0009.8597
The role of muscle depletion and visceral adiposity in HCC patients aged 65 and over undergoing TACE
2021 · BMC Cancer · 17 citations
https://doi.org/10.1186/s12885-021-08905-2
The associations between fibrosis changes and liver‐related events in patients with metabolic dysfunction‐associated steatotic liver disease
2024 · Liver International · 11 citations
https://doi.org/10.1111/liv.15897
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat